Show simple item record

Behcet's disease uveitis: is there a need for new emerging drugs?

dc.contributor.authorTugal-Tutkun, Ilknur
dc.contributor.authorOzdal, Pinar Cakar
dc.date.accessioned2021-03-04T09:27:39Z
dc.date.available2021-03-04T09:27:39Z
dc.identifier.citationTugal-Tutkun I., Ozdal P. C. , "Behcet's disease uveitis: is there a need for new emerging drugs?", EXPERT OPINION ON EMERGING DRUGS, 2020
dc.identifier.issn1472-8214
dc.identifier.othervv_1032021
dc.identifier.otherav_68561d14-1176-40de-8e5a-638be13ac4d7
dc.identifier.urihttp://hdl.handle.net/20.500.12627/72328
dc.identifier.urihttps://doi.org/10.1080/14728214.2020.1847271
dc.description.abstractIntroduction: Behcet's disease uveitis (BDU) is a potentially blinding disorder. Systemic treatment with disease-modifying anti-rheumatic drugs (DMARDs) is mandatory in patients with intraocular inflammation involving the posterior segment of the eye.
dc.language.isoeng
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.titleBehcet's disease uveitis: is there a need for new emerging drugs?
dc.typeMakale
dc.relation.journalEXPERT OPINION ON EMERGING DRUGS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID2486244


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record